High-definition mapping of retroviral integration sites identifies active regulatory elements in human multipotent hematopoietic progenitors

Claudia Cattoglio, Danilo Pellin, Ermanno Rizzi, Giulietta Maruggi, Giorgio Corti, Francesca Miselli, Daniela Sartori, Alessandro Guffanti, Clelia Di Serio, Alessandro Ambrosi, Gianluca De Bellis, Fulvio Mavilio

Research output: Contribution to journalArticle

106 Citations (Scopus)

Abstract

Integration of retroviral vectors in the human genome follows nonrandom patterns that favor insertional deregulation of gene expression and increase the risk of their use in clinical gene therapy. The molecular basis of retroviral target site selection is still poorly understood. We used deep sequencing technology to build genomewide, high-definition maps of > 60 000 integration sites of Moloney murine leukemia virus (MLV)-and HIV-based retroviral vectors in the genome of human CD34+ multipotent hematopoietic progenitor cells (HPCs) and used gene expression profiling, chromatin immunoprecipitation, and bioinformatics to associate integration to genetic and epigenetic features of the HPC genome. Clusters of recurrent MLV integrations identify regulatory elements (alternative promoters, enhancers, evolutionarily conserved noncoding regions) within or around protein-coding genes and microRNAs with crucial functions in HPC growth and differentiation, bearing epigenetic marks of active or poised transcription (H3K4me1, H3K4me2, H3K4me3, H3K9Ac, Pol II) and specialized chromatin configurations (H2A.Z). Overall, we mapped 3500 high-frequency integration clusters, which represent a new resource for the identification of transcriptionally active regulatory elements. High-definition MLV integration maps provide a rational basis for predicting genotoxic risks in gene therapy and a new tool for genomewide identification of promoters and regulatory elements controlling hematopoietic stem and progenitor cell functions.

Original languageEnglish
Pages (from-to)5507-5517
Number of pages11
JournalBlood
Volume116
Issue number25
DOIs
Publication statusPublished - Dec 16 2010

Fingerprint

Hematopoietic Stem Cells
Catalytic Domain
Virus Integration
Genes
Murine Leukemia Viruses
Viruses
Gene therapy
Human Genome
Epigenomics
Genetic Therapy
Gene expression
Chromatin
Moloney murine leukemia virus
Bearings (structural)
High-Throughput Nucleotide Sequencing
Chromatin Immunoprecipitation
Gene Expression Profiling
Site selection
Computational Biology
MicroRNAs

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

High-definition mapping of retroviral integration sites identifies active regulatory elements in human multipotent hematopoietic progenitors. / Cattoglio, Claudia; Pellin, Danilo; Rizzi, Ermanno; Maruggi, Giulietta; Corti, Giorgio; Miselli, Francesca; Sartori, Daniela; Guffanti, Alessandro; Di Serio, Clelia; Ambrosi, Alessandro; De Bellis, Gianluca; Mavilio, Fulvio.

In: Blood, Vol. 116, No. 25, 16.12.2010, p. 5507-5517.

Research output: Contribution to journalArticle

Cattoglio, C, Pellin, D, Rizzi, E, Maruggi, G, Corti, G, Miselli, F, Sartori, D, Guffanti, A, Di Serio, C, Ambrosi, A, De Bellis, G & Mavilio, F 2010, 'High-definition mapping of retroviral integration sites identifies active regulatory elements in human multipotent hematopoietic progenitors', Blood, vol. 116, no. 25, pp. 5507-5517. https://doi.org/10.1182/blood-2010-05-283523
Cattoglio, Claudia ; Pellin, Danilo ; Rizzi, Ermanno ; Maruggi, Giulietta ; Corti, Giorgio ; Miselli, Francesca ; Sartori, Daniela ; Guffanti, Alessandro ; Di Serio, Clelia ; Ambrosi, Alessandro ; De Bellis, Gianluca ; Mavilio, Fulvio. / High-definition mapping of retroviral integration sites identifies active regulatory elements in human multipotent hematopoietic progenitors. In: Blood. 2010 ; Vol. 116, No. 25. pp. 5507-5517.
@article{3d500e9d91e243ddb016a8761a79db22,
title = "High-definition mapping of retroviral integration sites identifies active regulatory elements in human multipotent hematopoietic progenitors",
abstract = "Integration of retroviral vectors in the human genome follows nonrandom patterns that favor insertional deregulation of gene expression and increase the risk of their use in clinical gene therapy. The molecular basis of retroviral target site selection is still poorly understood. We used deep sequencing technology to build genomewide, high-definition maps of > 60 000 integration sites of Moloney murine leukemia virus (MLV)-and HIV-based retroviral vectors in the genome of human CD34+ multipotent hematopoietic progenitor cells (HPCs) and used gene expression profiling, chromatin immunoprecipitation, and bioinformatics to associate integration to genetic and epigenetic features of the HPC genome. Clusters of recurrent MLV integrations identify regulatory elements (alternative promoters, enhancers, evolutionarily conserved noncoding regions) within or around protein-coding genes and microRNAs with crucial functions in HPC growth and differentiation, bearing epigenetic marks of active or poised transcription (H3K4me1, H3K4me2, H3K4me3, H3K9Ac, Pol II) and specialized chromatin configurations (H2A.Z). Overall, we mapped 3500 high-frequency integration clusters, which represent a new resource for the identification of transcriptionally active regulatory elements. High-definition MLV integration maps provide a rational basis for predicting genotoxic risks in gene therapy and a new tool for genomewide identification of promoters and regulatory elements controlling hematopoietic stem and progenitor cell functions.",
author = "Claudia Cattoglio and Danilo Pellin and Ermanno Rizzi and Giulietta Maruggi and Giorgio Corti and Francesca Miselli and Daniela Sartori and Alessandro Guffanti and {Di Serio}, Clelia and Alessandro Ambrosi and {De Bellis}, Gianluca and Fulvio Mavilio",
year = "2010",
month = "12",
day = "16",
doi = "10.1182/blood-2010-05-283523",
language = "English",
volume = "116",
pages = "5507--5517",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "25",

}

TY - JOUR

T1 - High-definition mapping of retroviral integration sites identifies active regulatory elements in human multipotent hematopoietic progenitors

AU - Cattoglio, Claudia

AU - Pellin, Danilo

AU - Rizzi, Ermanno

AU - Maruggi, Giulietta

AU - Corti, Giorgio

AU - Miselli, Francesca

AU - Sartori, Daniela

AU - Guffanti, Alessandro

AU - Di Serio, Clelia

AU - Ambrosi, Alessandro

AU - De Bellis, Gianluca

AU - Mavilio, Fulvio

PY - 2010/12/16

Y1 - 2010/12/16

N2 - Integration of retroviral vectors in the human genome follows nonrandom patterns that favor insertional deregulation of gene expression and increase the risk of their use in clinical gene therapy. The molecular basis of retroviral target site selection is still poorly understood. We used deep sequencing technology to build genomewide, high-definition maps of > 60 000 integration sites of Moloney murine leukemia virus (MLV)-and HIV-based retroviral vectors in the genome of human CD34+ multipotent hematopoietic progenitor cells (HPCs) and used gene expression profiling, chromatin immunoprecipitation, and bioinformatics to associate integration to genetic and epigenetic features of the HPC genome. Clusters of recurrent MLV integrations identify regulatory elements (alternative promoters, enhancers, evolutionarily conserved noncoding regions) within or around protein-coding genes and microRNAs with crucial functions in HPC growth and differentiation, bearing epigenetic marks of active or poised transcription (H3K4me1, H3K4me2, H3K4me3, H3K9Ac, Pol II) and specialized chromatin configurations (H2A.Z). Overall, we mapped 3500 high-frequency integration clusters, which represent a new resource for the identification of transcriptionally active regulatory elements. High-definition MLV integration maps provide a rational basis for predicting genotoxic risks in gene therapy and a new tool for genomewide identification of promoters and regulatory elements controlling hematopoietic stem and progenitor cell functions.

AB - Integration of retroviral vectors in the human genome follows nonrandom patterns that favor insertional deregulation of gene expression and increase the risk of their use in clinical gene therapy. The molecular basis of retroviral target site selection is still poorly understood. We used deep sequencing technology to build genomewide, high-definition maps of > 60 000 integration sites of Moloney murine leukemia virus (MLV)-and HIV-based retroviral vectors in the genome of human CD34+ multipotent hematopoietic progenitor cells (HPCs) and used gene expression profiling, chromatin immunoprecipitation, and bioinformatics to associate integration to genetic and epigenetic features of the HPC genome. Clusters of recurrent MLV integrations identify regulatory elements (alternative promoters, enhancers, evolutionarily conserved noncoding regions) within or around protein-coding genes and microRNAs with crucial functions in HPC growth and differentiation, bearing epigenetic marks of active or poised transcription (H3K4me1, H3K4me2, H3K4me3, H3K9Ac, Pol II) and specialized chromatin configurations (H2A.Z). Overall, we mapped 3500 high-frequency integration clusters, which represent a new resource for the identification of transcriptionally active regulatory elements. High-definition MLV integration maps provide a rational basis for predicting genotoxic risks in gene therapy and a new tool for genomewide identification of promoters and regulatory elements controlling hematopoietic stem and progenitor cell functions.

UR - http://www.scopus.com/inward/record.url?scp=78650447013&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650447013&partnerID=8YFLogxK

U2 - 10.1182/blood-2010-05-283523

DO - 10.1182/blood-2010-05-283523

M3 - Article

C2 - 20864581

AN - SCOPUS:78650447013

VL - 116

SP - 5507

EP - 5517

JO - Blood

JF - Blood

SN - 0006-4971

IS - 25

ER -